Prognostic value of mass spectrometry at defined time points.
DISEASE
Progression-free (PFS) and overall survival (OS) of GMMG-MM5 patients stratified by the mass spectrometry test result (negative/positive) after induction therapy (A recent study demonstrated that the extended half-life of IgG could impact disease monitoring by MS [